VFO
PROK icon

Virtus Family Office’s ProKidney PROK Stock Holding History

Virtus Family Office’s Portfolio PROK Stock Details PROK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$56.1K Hold
27,500
– – 0.04% 62
2026
Q1 		$49.2K Hold
27,500
– – 0.04% 73
2025
Q4 		$61.6K Hold
27,500
– – 0.05% 64
2025
Q3 		$66.5K Hold
27,500
– – 0.06% 52
2025
Q2 		$16.3K Hold
27,500
– – 0.02% 43
2025
Q1 		$24.1K Buy
+27,500
New +$38.2K 0.03% 40
2024
Q4 		– Sell
-27,500
Closed -$52.8K – 46
2024
Q3 		$52.8K Buy
+27,500
New +$62.4K 0.07% 47

Other funds holding PROK

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
AGP
Artia Global Partners Miami, Florida $542M AUM 206.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Virtus Family Office's PROK Position: Q2 2026 in Review

Virtus Family Office held its ProKidney (PROK) position steady in Q2 2026 at 27,500 shares worth $56.1K. The position accounts for 0.04% of the portfolio, ranked #62.

Virtus Family Office first reported a position in PROK in Q3 2024 and has held it in 7 quarters since. The position peaked at $66.5K in Q3 2025. 71 funds tracked by Wall St. Rank hold PROK as of Q2 2026.

  • Virtus Family Office held 27,500 shares of ProKidney worth $56.1K as of Q2 2026.
  • Virtus Family Office left its ProKidney share count unchanged in Q2 2026.
  • ProKidney made up 0.04% of Virtus Family Office's portfolio in Q2 2026, its #62 holding.
  • Virtus Family Office first reported a position in ProKidney in Q3 2024 and has held it in 7 quarters since.
  • Virtus Family Office's ProKidney position peaked at $66.5K in Q3 2025.
  • 71 funds tracked by Wall St. Rank held ProKidney as of Q2 2026.

Based on Virtus Family Office's 13F filing for Q2 2026, filed 4 Aug 2026.